{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T19:39:52Z","timestamp":1772134792201,"version":"3.50.1"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1038\/pr.2017.244","type":"journal-article","created":{"date-parts":[[2018,3,28]],"date-time":"2018-03-28T23:46:11Z","timestamp":1522280771000},"page":"318-324","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Inside out: regenerative medicine for recessive dystrophic epidermolysis bullosa"],"prefix":"10.1038","volume":"83","author":[{"given":"Michael","family":"Vanden Oever","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirk","family":"Twaroski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark J","family":"Osborn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John E","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakub","family":"Tolar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,11,1]]},"reference":[{"key":"BFpr2017244_CR1","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.det.2009.10.011","volume":"28","author":"HJ Chung","year":"2010","unstructured":"Chung HJ, Uitto J . Type VII collagen: the anchoring fibril protein at fault in dystrophic epidermolysis bullosa. Dermatol Clin 2010;28:93\u2013105.","journal-title":"Dermatol Clin"},{"key":"BFpr2017244_CR2","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/msb.2013.17","volume":"9","author":"V Kuttner","year":"2013","unstructured":"Kuttner V, Mack C, Rigbolt KT et al. Global remodelling of cellular microenvironment due to loss of collagen VII. Mol Syst Biol 2013;9:657.","journal-title":"Mol Syst Biol"},{"key":"BFpr2017244_CR3","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1038\/jid.2014.500","volume":"135","author":"MR Mack","year":"2015","unstructured":"Mack MR, Wendelschafer-Crabb G, McAdams BD, Hordinsky MK, Kennedy WR, Tolar J . Peripheral neuro-immune pathology in recessive dystrophic epidermolysis bullosa. J Invest Dermatol 2015;135:1193\u20131197.","journal-title":"J Invest Dermatol"},{"key":"BFpr2017244_CR4","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/pde.12243","volume":"31","author":"AY Kirkorian","year":"2014","unstructured":"Kirkorian AY, Weitz NA, Tlougan B, Morel KD . Evaluation of wound care options in patients with recessive dystrophic epidermolysis bullosa: a costly necessity. Pediatr Dermatol 2014;31:33\u201337.","journal-title":"Pediatr Dermatol"},{"key":"BFpr2017244_CR5","first-page":"S29","volume":"1","author":"A Kon","year":"2005","unstructured":"Kon A, Takeda H, Ito N, Hanada K, Takagaki K . Tissue-specific downregulation of type VII collagen gene (COL7A1 transcription in cultured epidermal keratinocytes by ultraviolet A radiation (UVA) and UVA-inducible cytokines, with special reference to cutaneous photoaging. J Dermatol Sci 2005;1:S29\u2013S35.","journal-title":"J Dermatol Sci"},{"key":"BFpr2017244_CR6","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1038\/jid.2011.85","volume":"131","author":"N Nagy","year":"2011","unstructured":"Nagy N, Almaani N, Tanaka A et al. HB-EGF induces COL7A1 expression in keratinocytes and fibroblasts: possible mechanism underlying allogeneic fibroblast therapy in recessive dystrophic epidermolysis bullosa. J Invest Dermatol 2011;131:1771\u20131774.","journal-title":"J Invest Dermatol"},{"key":"BFpr2017244_CR7","doi-asserted-by":"publisher","first-page":"3498","DOI":"10.1172\/JCI68127","volume":"123","author":"A Nystrom","year":"2013","unstructured":"Nystrom A, Velati D, Mittapalli VR, Fritsch A, Kern JS, Bruckner-Tuderman L . Collagen VII plays a dual role in wound healing. J Clin Invest 2013;123:3498\u20133509.","journal-title":"J Clin Invest"},{"key":"BFpr2017244_CR8","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1142\/S0218810407003614","volume":"12","author":"ES Moon","year":"2007","unstructured":"Moon ES, Jung ST, Kim MS . Surgical treatment of pseudosyndactyly of children with epidermolysis bullosa: a case report. Hand Surg 2007;12:143\u2013147.","journal-title":"Hand Surg"},{"key":"BFpr2017244_CR9","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.ajo.2004.03.034","volume":"138","author":"JD Fine","year":"2004","unstructured":"Fine JD, Johnson LB, Weiner M et al. Eye involvement in inherited epidermolysis bullosa: experience of the National Epidermolysis Bullosa Registry. Am J Ophthalmol 2004;138:254\u2013262.","journal-title":"Am J Ophthalmol"},{"key":"BFpr2017244_CR10","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1038\/sj.jid.5701086","volume":"127","author":"RS Kirsner","year":"2007","unstructured":"Kirsner RS, Hu S . Recessive dystrophic epidermolysis bullosa and squamous-cell carcinoma: the role of type VII collagen. J Invest Dermatol 2007;127:2292.","journal-title":"J Invest Dermatol"},{"key":"BFpr2017244_CR11","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1155\/2011\/153108","volume":"34","author":"J Knaup","year":"2011","unstructured":"Knaup J, Gruber C, Krammer B, Ziegler V, Bauer J, Verwanger T . TGFbeta-signaling in squamous cell carcinoma occurring in recessive dystrophic epidermolysis bullosa. Anal Cell Pathol 2011;34:339\u2013353.","journal-title":"Anal Cell Pathol"},{"key":"BFpr2017244_CR12","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1158\/0008-5472.CAN-15-1348","volume":"76","author":"VR Mittapalli","year":"2016","unstructured":"Mittapalli VR, Madl J, Loffek S et al. Injury-driven stiffening of the dermis expedites skin carcinoma progression. Cancer Res 2016;76:940\u2013951.","journal-title":"Cancer Res"},{"key":"BFpr2017244_CR13","doi-asserted-by":"publisher","first-page":"3522","DOI":"10.1158\/0008-5472.CAN-11-2996","volume":"72","author":"YZ Ng","year":"2012","unstructured":"Ng YZ, Pourreyron C, Salas-Alanis JC et al. Fibroblast-derived dermal matrix drives development of aggressive cutaneous squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa. Cancer Res 2012;72:3522\u20133534.","journal-title":"Cancer Res"},{"key":"BFpr2017244_CR14","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/jcp.10260","volume":"196","author":"EV Badiavas","year":"2003","unstructured":"Badiavas EV, Abedi M, Butmarc J, Falanga V, Quesenberry P . Participation of bone marrow derived cells in cutaneous wound healing. J Cell Physiol 2003;196:245\u2013250.","journal-title":"J Cell Physiol"},{"key":"BFpr2017244_CR15","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1182\/blood-2008-06-161299","volume":"113","author":"J Tolar","year":"2009","unstructured":"Tolar J, Ishida-Yamamoto A, Riddle M et al. Amelioration of epidermolysis bullosa by transfer of wild-type bone marrow cells. Blood 2009;113:1167\u20131174.","journal-title":"Blood"},{"key":"BFpr2017244_CR16","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1056\/NEJMoa0910501","volume":"363","author":"JE Wagner","year":"2010","unstructured":"Wagner JE, Ishida-Yamamoto A, McGrath JA et al. Bone marrow transplantation for recessive dystrophic epidermolysis bullosa. N Engl J Med 2010;363:629\u2013639.","journal-title":"N Engl J Med"},{"key":"BFpr2017244_CR17","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/S0140-6736(13)61897-8","volume":"382","author":"J Tolar","year":"2013","unstructured":"Tolar J, Wagner JE . Allogeneic blood and bone marrow cells for the treatment of severe epidermolysis bullosa: repair of the extracellular matrix. Lancet 2013;382:1214\u20131223.","journal-title":"Lancet"},{"key":"BFpr2017244_CR18","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.4049\/jimmunol.180.4.2581","volume":"180","author":"M Sasaki","year":"2008","unstructured":"Sasaki M, Abe R, Fujita Y, Ando S, Inokuma D, Shimizu H . Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type. J Immunol 2008;180:2581\u20132587.","journal-title":"J Immunol"},{"key":"BFpr2017244_CR19","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/scrt511","volume":"5","author":"C Perdoni","year":"2014","unstructured":"Perdoni C, McGrath JA, Tolar J . Preconditioning of mesenchymal stem cells for improved transplantation efficacy in recessive dystrophic epidermolysis bullosa. Stem Cell Res Ther 2014;5:121.","journal-title":"Stem Cell Res Ther"},{"key":"BFpr2017244_CR20","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1038\/jid.2015.158","volume":"135","author":"G Petrof","year":"2015","unstructured":"Petrof G, Lwin SM, Martinez-Queipo M et al. Potential of systemic allogeneic mesenchymal stromal cell therapy for children with recessive dystrophic epidermolysis bullosa. J Invest Dermatol 2015;135:2319\u20132321.","journal-title":"J Invest Dermatol"},{"key":"BFpr2017244_CR21","doi-asserted-by":"publisher","first-page":"6609","DOI":"10.1073\/pnas.1016753108","volume":"108","author":"K Tamai","year":"2011","unstructured":"Tamai K, Yamazaki T, Chino T et al. PDGFRalpha-positive cells in bone marrow are mobilized by high mobility group box 1 (HMGB1) to regenerate injured epithelia. Proc Natl Acad Sci USA 2011;108:6609\u20136614.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFpr2017244_CR22","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.4049\/jimmunol.1400914","volume":"194","author":"S Iinuma","year":"2015","unstructured":"Iinuma S, Aikawa E, Tamai K et al. Transplanted bone marrow-derived circulating PDGFRalpha+ cells restore type VII collagen in recessive dystrophic epidermolysis bullosa mouse skin graft. J Immunol 2015;194:1996\u20132003.","journal-title":"J Immunol"},{"key":"BFpr2017244_CR23","doi-asserted-by":"publisher","first-page":"5665","DOI":"10.1073\/pnas.76.11.5665","volume":"76","author":"H Green","year":"1979","unstructured":"Green H, Kehinde O, Thomas J . Growth of cultured human epidermal cells into multiple epithelia suitable for grafting. Proc Natl Acad Sci USA 1979;76:5665\u20135668.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFpr2017244_CR24","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1073\/pnas.84.8.2302","volume":"84","author":"Y Barrandon","year":"1987","unstructured":"Barrandon Y, Green H . Three clonal types of keratinocyte with different capacities for multiplication. Proc Natl Acad Sci USA 1987;84:2302\u20132306.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFpr2017244_CR25","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi K, Yamanaka S . Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663\u2013676.","journal-title":"Cell"},{"key":"BFpr2017244_CR26","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1126\/science.1151526","volume":"318","author":"J Yu","year":"2007","unstructured":"Yu J, Vodyanik MA, Smuga-Otto K et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007;318:1917\u20131920.","journal-title":"Science"},{"key":"BFpr2017244_CR27","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1126\/science.1152092","volume":"318","author":"J Hanna","year":"2007","unstructured":"Hanna J, Wernig M, Markoulaki S et al. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 2007;318:1920\u20131923.","journal-title":"Science"},{"key":"BFpr2017244_CR28","doi-asserted-by":"publisher","first-page":"140ra89","DOI":"10.1126\/scitranslmed.3003541","volume":"4","author":"FS Tedesco","year":"2012","unstructured":"Tedesco FS, Gerli MF, Perani L et al. Transplantation of genetically corrected human iPSC-derived progenitors in mice with limb-girdle muscular dystrophy. Sci Transl Med 2012;4:140ra89.","journal-title":"Sci Transl Med"},{"key":"BFpr2017244_CR29","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1056\/NEJMoa1608368","volume":"376","author":"M Mandai","year":"2017","unstructured":"Mandai M, Watanabe A, Kurimoto Y et al. Autologous induced stem-cell-derived retinal cells for macular degeneration. N Engl J Med 2017;376:1038\u20131046.","journal-title":"N Engl J Med"},{"key":"BFpr2017244_CR30","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/nature11807","volume":"494","author":"R Araki","year":"2013","unstructured":"Araki R, Uda M, Hoki Y et al. Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells. Nature 2013;494:100\u2013104.","journal-title":"Nature"},{"key":"BFpr2017244_CR31","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/jid.2010.346","volume":"131","author":"J Tolar","year":"2011","unstructured":"Tolar J, Xia L, Riddle MJ et al. Induced pluripotent stem cells from individuals with recessive dystrophic epidermolysis bullosa. J Invest Dermatol 2011;131:848\u2013856.","journal-title":"J Invest Dermatol"},{"key":"BFpr2017244_CR32","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/jid.2012.278","volume":"133","author":"J Tolar","year":"2013","unstructured":"Tolar J, Xia L, Lees CJ et al. Keratinocytes from induced pluripotent stem cells in junctional epidermolysis bullosa. J Invest Dermatol 2013;133:562\u2013565.","journal-title":"J Invest Dermatol"},{"key":"BFpr2017244_CR33","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.scr.2016.05.003","volume":"17","author":"M Itoh","year":"2016","unstructured":"Itoh M, Kawagoe S, Tamai K, Okano HJ, Nakagawa H . Integration-free T cell-derived human induced pluripotent stem cells (iPSCs) from a patient with recessive dystrophic epidermolysis bullosa (RDEB) carrying two compound heterozygous mutations in the COL7A1 gene. Stem Cell Res 2016;17:32\u201335.","journal-title":"Stem Cell Res"},{"key":"BFpr2017244_CR34","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1038\/jid.2013.523","volume":"134","author":"J Tolar","year":"2014","unstructured":"Tolar J, McGrath JA, Xia L et al. Patient-specific naturally gene-reverted induced pluripotent stem cells in recessive dystrophic epidermolysis bullosa. J Invest Dermatol 2014;134:1246\u20131254.","journal-title":"J Invest Dermatol"},{"key":"BFpr2017244_CR35","doi-asserted-by":"publisher","first-page":"264ra164","DOI":"10.1126\/scitranslmed.3009342","volume":"6","author":"N Umegaki-Arao","year":"2014","unstructured":"Umegaki-Arao N, Pasmooij AM, Itoh M et al. Induced pluripotent stem cells from human revertant keratinocytes for the treatment of epidermolysis bullosa. Sci Transl Med 2014;6:264ra164.","journal-title":"Sci Transl Med"},{"key":"BFpr2017244_CR36","doi-asserted-by":"publisher","first-page":"3906","DOI":"10.1182\/blood-2012-03-420703","volume":"120","author":"CJ Chang","year":"2012","unstructured":"Chang CJ, Bouhassira EE . Zinc-finger nuclease-mediated correction of alpha-thalassemia in iPS cells. Blood 2012;120:3906\u20133914.","journal-title":"Blood"},{"key":"BFpr2017244_CR37","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1038\/mt.2013.56","volume":"21","author":"MJ Osborn","year":"2013","unstructured":"Osborn MJ, Starker CG, McElroy AN et al. TALEN-based gene correction for epidermolysis bullosa. Mol Ther 2013;21:1151\u20131159.","journal-title":"Mol Ther"},{"key":"BFpr2017244_CR38","doi-asserted-by":"publisher","first-page":"264ra163","DOI":"10.1126\/scitranslmed.3009540","volume":"6","author":"V Sebastiano","year":"2014","unstructured":"Sebastiano V, Zhen HH, Haddad B et al. Human COL7A1-corrected induced pluripotent stem cells for the treatment of recessive dystrophic epidermolysis bullosa. Sci Transl Med 2014;6:264ra163.","journal-title":"Sci Transl Med"},{"key":"BFpr2017244_CR39","unstructured":"Webber BR, Osborn MJ, McElroy AN et al. CRISPR\/Cas9-based genetic correction for recessive dystrophic epidermolysis bullosa. NPJ Regen Med 2016 (e-pub ahead of print 8 December 2016; doi:10.1038\/npjregenmed.2016.14)."},{"key":"BFpr2017244_CR40","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13073-015-0141-7","volume":"7","author":"J Tolar","year":"2015","unstructured":"Tolar J, McGrath JA . The three-body problem of therapy with induced pluripotent stem cells. Genome Med 2015;7:15.","journal-title":"Genome Med"},{"key":"BFpr2017244_CR41","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/mt.2015.47","volume":"23","author":"BR Webber","year":"2015","unstructured":"Webber BR, Tolar J . From marrow to matrix: novel gene and cell therapies for epidermolysis bullosa. Mol Ther 2015;23:987\u2013992.","journal-title":"Mol Ther"},{"key":"BFpr2017244_CR42","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1007\/s12015-011-9249-3","volume":"7","author":"T Inoue","year":"2011","unstructured":"Inoue T, Kulkeaw K, Okayama S, Tani K, Sugiyama D . Variation in mesodermal and hematopoietic potential of adult skin-derived induced pluripotent stem cell lines in mice. Stem Cell Rev 2011;7:958\u2013968.","journal-title":"Stem Cell Rev"},{"key":"BFpr2017244_CR43","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1038\/mt.2013.71","volume":"21","author":"N Suzuki","year":"2013","unstructured":"Suzuki N, Yamazaki S, Yamaguchi T et al. Generation of engraftable hematopoietic stem cells from induced pluripotent stem cells by way of teratoma formation. Mol Ther 2013;21:1424\u20131431.","journal-title":"Mol Ther"},{"key":"BFpr2017244_CR44","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1182\/blood-2010-05-287607","volume":"117","author":"J Tolar","year":"2011","unstructured":"Tolar J, Park IH, Xia L et al. Hematopoietic differentiation of induced pluripotent stem cells from patients with mucopolysaccharidosis type I (Hurler syndrome). Blood 2011;117:839\u2013847.","journal-title":"Blood"},{"key":"BFpr2017244_CR45","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/nature22370","volume":"545","author":"R Sugimura","year":"2017","unstructured":"Sugimura R, Jha DK, Han A et al. Haematopoietic stem and progenitor cells from human pluripotent stem cells. Nature 2017;545:432\u2013438.","journal-title":"Nature"},{"key":"BFpr2017244_CR46","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1111\/bjd.12599","volume":"169","author":"G Petrof","year":"2013","unstructured":"Petrof G, Martinez-Queipo M, Mellerio JE, Kemp P, McGrath JA . Fibroblast cell therapy enhances initial healing in recessive dystrophic epidermolysis bullosa wounds: results of a randomized, vehicle-controlled trial. Br J Dermatol 2013;169:1025\u20131033.","journal-title":"Br J Dermatol"},{"key":"BFpr2017244_CR47","doi-asserted-by":"publisher","first-page":"e77673","DOI":"10.1371\/journal.pone.0077673","volume":"8","author":"M Itoh","year":"2013","unstructured":"Itoh M, Umegaki-Arao N, Guo Z, Liu L, Higgins CA, Christiano AM . Generation of 3D skin equivalents fully reconstituted from human induced pluripotent stem cells (iPSCs). PLoS ONE 2013;8:e77673.","journal-title":"PLoS ONE"},{"key":"BFpr2017244_CR48","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/scrt246","volume":"4","author":"JP Awe","year":"2013","unstructured":"Awe JP, Lee PC, Ramathal C et al. Generation and characterization of transgene-free human induced pluripotent stem cells and conversion to putative clinical-grade status. Stem Cell Res Ther 2013;4:87.","journal-title":"Stem Cell Res Ther"},{"key":"BFpr2017244_CR49","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/j.jid.2016.02.811","volume":"136","author":"J Jackow","year":"2016","unstructured":"Jackow J, Titeux M, Portier S et al. Gene-corrected fibroblast therapy for recessive dystrophic epidermolysis bullosa using a self-inactivating COL7A1 retroviral vector. J Invest Dermatol 2016;136:1346\u20131354.","journal-title":"J Invest Dermatol"},{"key":"BFpr2017244_CR50","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1089\/hum.2004.15.921","volume":"15","author":"Y Gache","year":"2004","unstructured":"Gache Y, Baldeschi C, Del Rio M et al. Construction of skin equivalents for gene therapy of recessive dystrophic epidermolysis bullosa. Hum Gene Ther 2004;15:921\u2013933.","journal-title":"Hum Gene Ther"},{"key":"BFpr2017244_CR51","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1038\/mt.2010.91","volume":"18","author":"M Titeux","year":"2010","unstructured":"Titeux M, Pendaries V, Zanta-Boussif MA et al. SIN retroviral vectors expressing COL7A1 under human promoters for ex vivo gene therapy of recessive dystrophic epidermolysis bullosa. Mol Ther 2010;18:1509\u20131518.","journal-title":"Mol Ther"},{"key":"BFpr2017244_CR52","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1001\/jama.2016.15588","volume":"316","author":"Z Siprashvili","year":"2016","unstructured":"Siprashvili Z, Nguyen NT, Gorell ES et al. Safety and wound outcomes following genetically corrected autologous epidermal grafts in patients with recessive dystrophic epidermolysis bullosa. JAMA 2016;316:1808\u20131817.","journal-title":"JAMA"},{"key":"BFpr2017244_CR53","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/ng1041","volume":"32","author":"M Chen","year":"2002","unstructured":"Chen M, Kasahara N, Keene DR et al. Restoration of type VII collagen expression and function in dystrophic epidermolysis bullosa. Nat Genet 2002;32:670\u2013675.","journal-title":"Nat Genet"},{"key":"BFpr2017244_CR54","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/JID.2015.364","volume":"136","author":"C Georgiadis","year":"2016","unstructured":"Georgiadis C, Syed F, Petrova A et al. Lentiviral engineered fibroblasts expressing codon-optimized COL7A1 restore anchoring fibrils in RDEB. J Invest Dermatol 2016;136:284\u2013292.","journal-title":"J Invest Dermatol"},{"key":"BFpr2017244_CR55","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1039\/C5BM00216H","volume":"4","author":"L Cutlar","year":"2016","unstructured":"Cutlar L, Gao Y, Aied A et al. A knot polymer mediated non-viral gene transfection for skin cells. Biomater Sci 2016;4:92\u201395.","journal-title":"Biomater Sci"},{"key":"BFpr2017244_CR56","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.jid.2016.11.038","volume":"137","author":"MC Latella","year":"2017","unstructured":"Latella MC, Cocchiarella F, De Rosa L et al. Correction of recessive dystrophic epidermolysis bullosa by transposon-mediated integration of COL7A1 in transplantable patient-derived primary keratinocytes. J Invest Dermatol 2017;137:836\u2013844.","journal-title":"J Invest Dermatol"},{"key":"BFpr2017244_CR57","doi-asserted-by":"publisher","first-page":"2614","DOI":"10.1038\/sj.jid.5700435","volume":"126","author":"M Goto","year":"2006","unstructured":"Goto M, Sawamura D, Nishie W et al. Targeted skipping of a single exon harboring a premature termination codon mutation: implications and potential for gene correction therapy for selective dystrophic epidermolysis bullosa patients. J Invest Dermatol 2006;126:2614\u20132620.","journal-title":"J Invest Dermatol"},{"key":"BFpr2017244_CR58","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1016\/j.jid.2016.07.029","volume":"136","author":"S Turczynski","year":"2016","unstructured":"Turczynski S, Titeux M, Tonasso L, Decha A, Ishida-Yamamoto A, Hovnanian A . Targeted exon skipping restores type VII collagen expression and anchoring fibril formation in an in vivo RDEB model. J Invest Dermatol 2016;136:2387\u20132395.","journal-title":"J Invest Dermatol"},{"key":"BFpr2017244_CR59","doi-asserted-by":"publisher","first-page":"e379","DOI":"10.1038\/mtna.2016.87","volume":"5","author":"J Bremer","year":"2016","unstructured":"Bremer J, Bornert O, Nystrom A et al. Antisense oligonucleotide-mediated exon skipping as a systemic therapeutic approach for recessive dystrophic epidermolysis bullosa. Mol Ther Nucleic Acids 2016;5:e379.","journal-title":"Mol Ther Nucleic Acids"},{"key":"BFpr2017244_CR60","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/jid.2010.249","volume":"131","author":"EM Murauer","year":"2011","unstructured":"Murauer EM, Gache Y, Gratz IK et al. Functional correction of type VII collagen expression in dystrophic epidermolysis bullosa. J Invest Dermatol 2011;131:74\u201383.","journal-title":"J Invest Dermatol"},{"key":"BFpr2017244_CR61","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/gt.2016.57","volume":"23","author":"B Tockner","year":"2016","unstructured":"Tockner B, Kocher T, Hainzl S et al. Construction and validation of an RNA trans-splicing molecule suitable to repair a large number of COL7A1 mutations. Gene Ther 2016;23:775\u2013784.","journal-title":"Gene Ther"},{"key":"BFpr2017244_CR62","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1534\/genetics.111.131433","volume":"188","author":"D Carroll","year":"2011","unstructured":"Carroll D . Genome engineering with zinc-finger nucleases. Genetics 2011;188:773\u2013782.","journal-title":"Genetics"},{"key":"BFpr2017244_CR63","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.tibtech.2013.04.004","volume":"31","author":"T Gaj","year":"2013","unstructured":"Gaj T, Gersbach CA, Barbas CF 3rd . ZFN, TALEN, and CRISPR\/Cas-based methods for genome engineering. Trends Biotechnol 2013;31:397\u2013405.","journal-title":"Trends Biotechnol"},{"key":"BFpr2017244_CR64","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/nbt.2170","volume":"30","author":"D Reyon","year":"2012","unstructured":"Reyon D, Tsai SQ, Khayter C, Foden JA, Sander JD, Joung JK . FLASH assembly of TALENs for high-throughput genome editing. Nat Biotechnol 2012;30:460\u2013465.","journal-title":"Nat Biotechnol"},{"key":"BFpr2017244_CR65","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1073\/pnas.1614775114","volume":"114","author":"W Wu","year":"2017","unstructured":"Wu W, Lu Z, Li F et al. Efficient in vivo gene editing using ribonucleoproteins in skin stem cells of recessive dystrophic epidermolysis bullosa mouse model. Proc Natl Acad Sci USA 2017;114:1660\u20131665.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFpr2017244_CR66","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1038\/mt.2014.140","volume":"22","author":"J Cogan","year":"2014","unstructured":"Cogan J, Weinstein J, Wang X et al. Aminoglycosides restore full-length type VII collagen by overcoming premature termination codons: therapeutic implications for dystrophic epidermolysis bullosa. Mol Ther 2014;22:1741\u20131752.","journal-title":"Mol Ther"},{"key":"BFpr2017244_CR67","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.1038\/jid.2015.291","volume":"135","author":"Y Hou","year":"2015","unstructured":"Hou Y, Guey LT, Wu T et al. Intravenously administered recombinant human type VII collagen derived from Chinese hamster ovary cells reverses the disease phenotype in recessive dystrophic epidermolysis bullosa mice. J Invest Dermatol 2015;135:3060\u20133067.","journal-title":"J Invest Dermatol"},{"key":"BFpr2017244_CR68","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.15252\/emmm.201505061","volume":"7","author":"A Nystrom","year":"2015","unstructured":"Nystrom A, Thriene K, Mittapalli V et al. Losartan ameliorates dystrophic epidermolysis bullosa and uncovers new disease mechanisms. EMBO Mol Med 2015;7:1211\u20131228.","journal-title":"EMBO Mol Med"},{"key":"BFpr2017244_CR69","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1038\/mt.2013.87","volume":"21","author":"X Wang","year":"2013","unstructured":"Wang X, Ghasri P, Amir M et al. Topical application of recombinant type VII collagen incorporates into the dermal-epidermal junction and promotes wound closure. Mol Ther 2013;21:1335\u20131344.","journal-title":"Mol Ther"},{"key":"BFpr2017244_CR70","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jpeds.2015.05.051","volume":"167","author":"MB Geyer","year":"2015","unstructured":"Geyer MB, Radhakrishnan K, Giller R et al. Reduced toxicity conditioning and allogeneic hematopoietic progenitor cell transplantation for recessive dystrophic epidermolysis bullosa. J Pediatr 2015;167:e1.","journal-title":"J Pediatr"},{"key":"BFpr2017244_CR71","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3727\/096368913X663569","volume":"23","author":"Y Liao","year":"2014","unstructured":"Liao Y, Itoh M, Yang A et al. Human cord blood-derived unrestricted somatic stem cells promote wound healing and have therapeutic potential for patients with recessive dystrophic epidermolysis bullosa. Cell Transplant 2014;23:303\u2013317.","journal-title":"Cell Transplant"},{"key":"BFpr2017244_CR72","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3109\/14653241003587637","volume":"12","author":"P Conget","year":"2010","unstructured":"Conget P, Rodriguez F, Kramer S et al. Replenishment of type VII collagen and re-epithelialization of chronically ulcerated skin after intradermal administration of allogeneic mesenchymal stromal cells in two patients with recessive dystrophic epidermolysis bullosa. Cytotherapy 2010;12:429\u2013431.","journal-title":"Cytotherapy"},{"key":"BFpr2017244_CR73","doi-asserted-by":"publisher","first-page":"7556","DOI":"10.4049\/jimmunol.166.12.7556","volume":"166","author":"R Abe","year":"2001","unstructured":"Abe R, Donnelly SC, Peng T, Bucala R, Metz CN . Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol 2001;166:7556\u20137562.","journal-title":"J Immunol"},{"key":"BFpr2017244_CR74","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1038\/nm1328","volume":"11","author":"M Ito","year":"2005","unstructured":"Ito M, Liu Y, Yang Z et al. Stem cells in the hair follicle bulge contribute to wound repair but not to homeostasis of the epidermis. Nat Med 2005;11:1351\u20131354.","journal-title":"Nat Med"},{"key":"BFpr2017244_CR75","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/mi.2015.63","volume":"8","author":"G Leoni","year":"2015","unstructured":"Leoni G, Neumann PA, Sumagin R, Denning TL, Nusrat A . Wound repair: role of immune-epithelial interactions. Mucosal Immunol 2015;8:959\u2013968.","journal-title":"Mucosal Immunol"},{"key":"BFpr2017244_CR76","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.1634\/stemcells.2006-0264","volume":"24","author":"D Inokuma","year":"2006","unstructured":"Inokuma D, Abe R, Fujita Y et al. CTACK\/CCL27 accelerates skin regeneration via accumulation of bone marrow-derived keratinocytes. Stem Cells 2006;24:2810\u20132816.","journal-title":"Stem Cells"},{"key":"BFpr2017244_CR77","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1038\/jid.2013.10","volume":"133","author":"DT Woodley","year":"2013","unstructured":"Woodley DT, Wang X, Amir M et al. Intravenously injected recombinant human type VII collagen homes to skin wounds and restores skin integrity of dystrophic epidermolysis bullosa. J Invest Dermatol 2013;133:1910\u20131913.","journal-title":"J Invest Dermatol"},{"key":"BFpr2017244_CR78","doi-asserted-by":"publisher","first-page":"e45435","DOI":"10.1371\/journal.pone.0045435","volume":"7","author":"R Hayashi","year":"2012","unstructured":"Hayashi R, Ishikawa Y, Ito M et al. Generation of corneal epithelial cells from induced pluripotent stem cells derived from human dermal fibroblast and corneal limbal epithelium. PLoS ONE 2012;7:e45435.","journal-title":"PLoS ONE"},{"key":"BFpr2017244_CR79","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1056\/NEJMoa0905955","volume":"363","author":"P Rama","year":"2010","unstructured":"Rama P, Matuska S, Paganoni G, Spinelli A, De Luca M, Pellegrini G . Limbal stem-cell therapy and long-term corneal regeneration. N Engl J Med 2010;363:147\u2013155.","journal-title":"N Engl J Med"},{"key":"BFpr2017244_CR80","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1056\/NEJMcibr1414709","volume":"372","author":"J Tolar","year":"2015","unstructured":"Tolar J, Wagner JE . A biologic Velcro patch. N Engl J Med 2015;372:382\u2013384.","journal-title":"N Engl J Med"}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/pr2017244.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/pr2017244","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/pr.2017.244","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/pr2017244.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T17:03:35Z","timestamp":1684602215000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/pr2017244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,1]]},"references-count":80,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["BFpr2017244"],"URL":"https:\/\/doi.org\/10.1038\/pr.2017.244","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.732985783.793548157","asserted-by":"object"}]},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,1]]},"assertion":[{"value":"21 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}